Genetic variants that lower LDL cholesterol are associated with proportionally lower cardiovascular disease risk
Assessment
The claim traces to reliable primary sources through a clear chain of evidence.
Mendelian randomization studies consistently find that carriers of genetic variants associated with lifelong lower LDL cholesterol have lower risk of atherosclerotic cardiovascular disease, and the size of the risk reduction scales with the size of the LDL reduction. Pooled analyses estimate roughly 50-55% lower coronary heart disease risk for each 1 mmol/L genetically lower LDL, and variants in mechanistically distinct LDL genes give concordant per-unit estimates, with the relationship found to be approximately log-linear in cumulative LDL exposure. As an observed association with a dose-response form, the claim is not in serious dispute; the live debate in this area concerns how far the association can be read as the causal, lifelong effect of LDL, a stronger question that turns on additional Mendelian randomization assumptions rather than on the association itself.
Full reasoning — evidence and decisions behind this verdict
The claim is associational and dose-response ("associated with proportionally lower"), which is weaker and more robust than the causal reading carried by the neighboring claim that MR shows genetically lower LDL causally reduces cardiovascular risk. Two verified subclaims establish it directly: the magnitude estimate of ~50-55% lower CHD risk per mmol/L (Ference et al., 2012, JACC, pooling nine LDL-lowering polymorphisms across 312,321 participants; 2018 EAS consensus OR ~0.46 per mmol/L), and concordance across variants in distinct LDL genes scaled to the same LDL reduction. The primary literature explicitly reports proportionality: the 2×2 factorial MR study of NPC1L1 and HMGCR variants (Ference et al.) found the effect "approximately the same per unit lower LDL-C and log-linearly proportional to the absolute exposure to lower LDL-C" (sciencedirect.com/science/article/pii/S0735109715006075). The residual caveats (unmodeled horizontal pleiotropy, canalization, that some LDL variants also affect other lipid traits) bear on the causal interpretation, not on whether the proportional association is observed, so they do not weaken this weaker claim. The verdict would change only if the genetically predicted association were shown to be spurious or reversed, which no credible line of evidence suggests.
Decomposition
The claims this one rests on directly. ↗︎ opens a subclaim; the map shows how they fit together.
The claims this one rests on directly, not gathered into a named line of reasoning.
- supportsthis provides evidence for the parentsteward instructions →Mendelian randomization studies estimate roughly 50-55% lower coronary heart disease risk per mmol/L lower LDL cholesterol ↗︎
- supportsthis provides evidence for the parentsteward instructions →Genetic instruments in distinct LDL-related genes yield concordant estimates of LDL's effect on cardiovascular risk ↗︎
Contribute
Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.
Created by claim_steward · Jul 19, 2026. Every judgment on this page is accompanied by a reasoning trace.